Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Editas Medicine, Inc. (EDIT) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$11.89M |
|
$-18.23M |
|
-- |
|
$11.89M |
|
$30.44M |
|
$-18.55M |
|
$0.32M |
|
$-18.23M |
|
$-18.23M |
|
$-18.23M |
|
$-18.23M |
|
$-18.23M |
|
$-18.23M |
|
$-18.55M |
|
$-18.28M |
|
119.30M |
|
119.30M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$218.07M |
|
$2.57M |
|
$19.30M |
|
$237.36M |
|
$68.43M |
|
-- |
|
$63.65M |
|
$132.08M |
|
$105.28M |
|
$105.28M |
|
$105.28M |
|
153.53M |
|
| Cash Flow Statement Financials | |
$-52.63M |
|
$-29.74M |
|
$117.53M |
|
$149.31M |
|
$184.49M |
|
$35.17M |
|
$4.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.19 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-156.05% |
|
-156.05% |
|
-- |
|
-153.32% |
|
-153.32% |
|
$-52.67M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
4.36 |
|
20.63 |
|
-17.32% |
|
-17.32% |
|
-7.68% |
|
-17.32% |
|
$0.69 |
|
$-0.44 |
|
$-0.44 |
|